In this podcast episode, Lisa Jones, MA, RDN, LDN, FAND, interviews Rachel Stahl Salzman, MS, RDN, CDN, CDCES, and Livleen Gill, MBA, RDN, LDN, FAND, on the benefits and challenges of telemedicine in...
In this podcast, Risa M. Wolf, MD, discusses the impact of social determinants of health, such as socioeconomic status, geography, and health care access and affordability, on the screening, prevalence, and...
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
Rachel Stahl Salzman, MS, RDN, CDCES; Lisa Jones, MA, RDN, LDN, FAND
Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...
In this podcast, Jennifer Smith, RD, LD, CDCES, discusses different mobile apps for diabetes management that she would recommend to people with diabetes, including women, women who are pregnant,...
In this podcast episode, Lisa Jones, MA, RDN, LDN, FAND, interviews Rachel Stahl Salzman, MS, RDN, CDN, CDCES, and Livleen Gill, MBA, RDN, LDN, FAND, on the use of continuous glucose monitoring (CGM) in...
In this podcast, Joëlle E. Vergroesen, MSc, discusses the results of her team's study examining how the use of metformin, insulin, and sulfonylurea derivatives may impact the risk of open-angle glaucoma,...
In this episode, Lisa Jones interviews Priscilla F. Thomas, MS, RN, RDN, LDN, CDCES, CCM, and Sandra Arevalo MPH, RDN, CDN, CDE, CLC, FADA, on diabetes management, including common diabetes misconceptions,...
In their single-center study, Viral Shah, MD, and his research team analyzed the association between diabetes technology use and mean clinic hemoglobin A1C among adults with type 1 diabetes.
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
